Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Seong Hwan | - |
dc.contributor.author | Cho, Kyung-Hwan | - |
dc.contributor.author | Yang, Beom-Seok | - |
dc.contributor.author | Roh, Yong Kyun | - |
dc.date.accessioned | 2024-01-21T02:33:04Z | - |
dc.date.available | 2024-01-21T02:33:04Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2006-09 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/135203 | - |
dc.description.abstract | Danshen is an herbal medication frequently used in oriental medicine to treat liver or kidney malfunction. In the course of our studies, we observed that compounds purified from Danshen exhibit an inhibitory activity against Discoidin Domain Receptor 2 (DDR2) tyrosine kinase. Through this inhibition, these compounds also inhibited the growth of HSC T6 cells and suppressed the expression of alpha-smooth muscle actin and MMP2, as well as collagen synthesis, all of which are increased in activated liver stellate cells. Given that activation of liver stellate cells is the hallmark of liver fibrosis and that DDR2 plays a critical role in this activation, these results suggest that one of the pharmacological activities of Danshen extract that protects the liver is the inhibition of key cell-signaling kinases, such as DDR2, in liver stellate cells. | - |
dc.language | English | - |
dc.publisher | PHARMACEUTICAL SOC KOREA | - |
dc.subject | DISCOIDIN DOMAIN RECEPTOR-1 | - |
dc.subject | SALVIA-MILTIORRHIZA | - |
dc.subject | PROLIFERATION | - |
dc.subject | ACTIVATION | - |
dc.subject | MIGRATION | - |
dc.subject | KINASES | - |
dc.subject | MATRIX | - |
dc.title | Natural compounds from Danshen suppress the activity of hepatic stellate cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1007/BF02974077 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | ARCHIVES OF PHARMACAL RESEARCH, v.29, no.9, pp.762 - 767 | - |
dc.citation.title | ARCHIVES OF PHARMACAL RESEARCH | - |
dc.citation.volume | 29 | - |
dc.citation.number | 9 | - |
dc.citation.startPage | 762 | - |
dc.citation.endPage | 767 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.identifier.wosid | 000240882200008 | - |
dc.identifier.scopusid | 2-s2.0-33749318518 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | DISCOIDIN DOMAIN RECEPTOR-1 | - |
dc.subject.keywordPlus | SALVIA-MILTIORRHIZA | - |
dc.subject.keywordPlus | PROLIFERATION | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | KINASES | - |
dc.subject.keywordPlus | MATRIX | - |
dc.subject.keywordAuthor | Danshen | - |
dc.subject.keywordAuthor | fibrosis | - |
dc.subject.keywordAuthor | liver stellate cell | - |
dc.subject.keywordAuthor | kinase inhibitor | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.